Skip to content

New laser treatment of MTM study

Novel minimum invasive laser therapy for the treatment of myopic traction maculopathy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032190239
Enrollment
15
Registered
2020-03-04
Start date
2020-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopic traction maculopathy

Interventions

YAG laser incision of internal limitting membrane at several points of ocular fundus.

Sponsors

Ohno-Matsui Kyoko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Myopic traction maculopathy with ocular axial length of more than 26.5 mm 2) Decreased visual acuity caused by myopic traction maculopathy which diagnosed by two ophthalomologists who are specialized in myopia 3) Age of more than 20 years old 4) Written informed consent 5) Judged as an appropriate study participant by two ophthalomologists who are specialized in myopia

Exclusion criteria

Exclusion criteria: 1) Pupil diameter of less than 3 mm with mydriatic examination 2) Opacity of cornea, lens, or vitreous which prevent image examination of ocular fundi. 3) Severe cardiopulmonary disease 4) Disability to keep sitting position 5) Judged as an inappropriate study participant by two ophthalomologists who are specialized in myopia

Design outcomes

Primary

MeasureTime frame
Retinal thickness at treated cite 6 months after treatment

Secondary

MeasureTime frame
Central retinal thickness at treated cites and visual acuity at 6 months after treatment

Contacts

Public ContactHiroyuki Takahashi

Tokyo Medical and Dental University

t.hiroyuki.oph@tmd.ac.jp+81-3-5803-5681

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026